東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Molecular mechanisms of retina patho...

Trofimova, Svetlana.

FindBook

Google Book

Amazon

博客來

Molecular mechanisms of retina pathology and ways of its correction

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Molecular mechanisms of retina pathology and ways of its correction/ by Svetlana Trofimova.
作者:	Trofimova, Svetlana.
出版者:	Cham :Springer International Publishing : : 2020.,
面頁冊數:	vi, 90 p. :ill., digital ;24 cm.
內容註:	Chapter 1. Literature review -- Chapter 2. Results of experimental studies of short peptides (cytogens) in ophthalmology -- Chapter 3. Results of the clinical study of short peptides (cytogens) in ophthalmology -- Conclusion.
Contained By:	Springer Nature eBook
標題:	Retina - Diseases -
電子資源:	https://doi.org/10.1007/978-3-030-50160-0
ISBN:	9783030501600

Molecular mechanisms of retina pathology and ways of its correction
Trofimova, Svetlana.

Molecular mechanisms of retina pathology and ways of its correction[electronic resource] /by Svetlana Trofimova. - Cham :Springer International Publishing :2020. - vi, 90 p. :ill., digital ;24 cm.

Chapter 1. Literature review -- Chapter 2. Results of experimental studies of short peptides (cytogens) in ophthalmology -- Chapter 3. Results of the clinical study of short peptides (cytogens) in ophthalmology -- Conclusion.

This book discusses the pathology of the retina, and reviews current research on the use of cell replacement therapy and short peptides to restore functional activity in retinal neurons. As the book describes, pathologies of the retina, including age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa, present a long-standing challenge in the practice of clinical ophthalmology. Modern treatment for these conditions, which lead to irreversible blindness, includes laser exposure, surgical intervention, and drugs. These treatments aim to reduce the risk of new complications in the eye; pathogenetic therapy of degenerative diseases of the retina is practically absent in current ophthalmic practice. The first section of the book reviews the molecular mechanisms of age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa, and reports on methods of treatment. The second section presents the results of recent experimental studies of the effects of short peptides on pluripotent embryonic cells; on proliferative activity in retinal cells and pigment epithelium; on expression of markers of differentiation or retinal neurons and pigment epithelium; and on the course of hereditary retinal pigmentation in Campbell rats. The third section offers results of clinical studies on the effectiveness of short peptides in patients with macular degeneration, and in patients with retinitis pigmentosa. The author concludes that the regular use of peptides in the treatment of degenerative diseases of the retina can slow the progression of the pathological process and preserve the patient's vision for some 10-15 years. In addition, in 80 percent of patients, it is possible to increase visual function by increasing visual acuity, improving the boundaries of the visual field and the fundus.

ISBN: 9783030501600

Standard No.: 10.1007/978-3-030-50160-0doiSubjects--Topical Terms:

836050
Retina
--Diseases

LC Class. No.: RE551 / .T764 2020

Dewey Class. No.: 617.735

Molecular mechanisms of retina pathology and ways of its correction
LDR:03065nmm a2200325 a 4500 001 2222236
003 DE-He213
005 20201106150347.0
006 m d
007 cr nn 008maaau
008 210108s2020 sz s 0 eng d
020 $a 9783030501600 $q (electronic bk.)
020 $a 9783030501594 $q (paper)
024 7 $a 10.1007/978-3-030-50160-0 $2 doi
035 $a 978-3-030-50160-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RE551 $b .T764 2020
072 7 $a MBGR $2 bicssc
072 7 $a MED000000 $2 bisacsh
072 7 $a MBGR $2 thema
082 0 4 $a 617.735 $2 23
090 $a RE551 $b .T843 2020
100 1 $a Trofimova, Svetlana. $3 3460810
245 1 0 $a Molecular mechanisms of retina pathology and ways of its correction $h [electronic resource] / $c by Svetlana Trofimova.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a vi, 90 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1. Literature review -- Chapter 2. Results of experimental studies of short peptides (cytogens) in ophthalmology -- Chapter 3. Results of the clinical study of short peptides (cytogens) in ophthalmology -- Conclusion.
520 $a This book discusses the pathology of the retina, and reviews current research on the use of cell replacement therapy and short peptides to restore functional activity in retinal neurons. As the book describes, pathologies of the retina, including age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa, present a long-standing challenge in the practice of clinical ophthalmology. Modern treatment for these conditions, which lead to irreversible blindness, includes laser exposure, surgical intervention, and drugs. These treatments aim to reduce the risk of new complications in the eye; pathogenetic therapy of degenerative diseases of the retina is practically absent in current ophthalmic practice. The first section of the book reviews the molecular mechanisms of age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa, and reports on methods of treatment. The second section presents the results of recent experimental studies of the effects of short peptides on pluripotent embryonic cells; on proliferative activity in retinal cells and pigment epithelium; on expression of markers of differentiation or retinal neurons and pigment epithelium; and on the course of hereditary retinal pigmentation in Campbell rats. The third section offers results of clinical studies on the effectiveness of short peptides in patients with macular degeneration, and in patients with retinitis pigmentosa. The author concludes that the regular use of peptides in the treatment of degenerative diseases of the retina can slow the progression of the pathological process and preserve the patient's vision for some 10-15 years. In addition, in 80 percent of patients, it is possible to increase visual function by increasing visual acuity, improving the boundaries of the visual field and the fundus.
650 0 $a Retina $x Diseases $x Molecular aspects. $3 836050
650 1 4 $a Biomedicine, general. $3 3446035
650 2 4 $a Geriatrics/Gerontology. $3 894395
650 2 4 $a Ophthalmology. $3 862704
650 2 4 $a Pathology. $3 643180
650 2 4 $a Cell Biology. $3 892383
650 2 4 $a Pharmacy. $3 636101
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-50160-0
950 $a Biomedical and Life Sciences (SpringerNature-11642)